Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity

Cell

Volumn 104, Issue 5, 2001, Pages 719-730

  Kousteni, S ^a   Bellido, T ^a   Plotkin, L I ^a   O'Brien, C A ^a   Bodenner, D L ^a   Han, L ^a   Han, K ^a   DiGregorio, G B ^a   Katzenellenbogen, J A ^b   Katzenellenbogen, B S ^b   Roberson, P K ^a   Weinstein, R S ^a   Jilka, R L ^a   Manolagas, S C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUTAMIDE; FULVESTRANT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0035831020     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0092-8674(01)00268-9     Document Type: Article

References (49)

1. 11 Beta-chloromethyl-[3H]estradiol-17 beta: A very high affinity, reversible ligand for the estrogen receptor
2. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae
3. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors alpha and beta
4. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding
5. Evidence of estrogen receptors in normal human osteoblast-like cells
6. Integrins and anoikis
7. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
8. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
9. Increased bone formation by prevention of osteoblast apoptosis with PTH
10. The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution
11. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts
12. Establishment of an osteocyte-like cell line, MLO-Y4
13. Stilbestrols and stilbestrol derivatives: Estrogenic potency and temporal relationships between estrogen receptor binding and uterine growth
14. Estrogen and antiestrogen action in reproductive tissues and tumors
15. Estrogen receptors: Selective ligands, partners, and distinctive pharmacology
16. Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils
17. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells
18. Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors
19. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
20. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2
21. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
22. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
23. Transformation of mammalian cells by constitutively active MAP kinase kinase
24. Estrogen actions in the central nervous system
25. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
26. Nuclear receptor coregulators: Cellular and molecular biology
27. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
28. The behavior and significance of slow-binding enzyme inhibitors
29. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription
30. Osteocyte function, osteocyte death and bone fracture resistance
31. Peptide antagonists of the human estrogen receptor
32. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
33. Oestrogen effects on osteoblasts and osteoclasts
34. Prevention of osteocyte and osteoblasts apoptosis by bisphosphonates and calcitonin
35. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism
36. 11 Beta-methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17beta-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues
37. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
38. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha
39. Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness
40. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
41. Caveolin-enriched membrane signaling complexes in human and murine osteoblasts
42. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
43. Kinetics of slow and tight-binding inhibitors
44. Action of androgens versus estrogens in male skeletal homeostasis
45. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc
46. Membrane-initiated steroid actions and the proteins that mediate them
47. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: Potential mechanisms of their deleterious effects on bone
48. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast
49. Integrin engagement, the actin cytoskeleton, and c-Src are required for the induction by calcitonin of the tyrosine phosphorylation of paxillin and HEF1, but not for calcitonin-induced ERK1/2 phosphorylation